Assembly for a medication delivery device and medication delivery device

Abstract

An assembly (47) for a medication delivery device (1) has a body (2), a dose setting part (8) configured to be operated by a user for selecting a size of a dose, a piston rod (13) configured to be moved axially without rotating for dispensing a medication, and a drive member (12) being directly coupled to the piston rod (13) for driving the piston rod (13) in a dose dispensing operation, wherein the drive member (12) moves in a proximal direction in a dose setting operation. The medication delivery device (1) into which the assembly is incorporated may be a single-shot, variable-dose injection device, e.g., a syringe.

Claims

1. An assembly for a medication delivery device, the assembly comprising: a body, a user operated dose setting part for selecting a size of a dose in a dose setting operation, a piston rod configured to be moved axially without rotating for dispensing a medication in a dose dispensing operation, and a drive member directly coupled to the piston rod for driving the piston rod in the dose dispensing operation, wherein the drive member moves in a proximal direction in the dose setting operation, wherein the dose setting part is coupled to the drive member such that a relative movement between the dose setting part and the drive member is enabled during the dose setting operation.

2. The assembly of claim 1, wherein the drive member protrudes out of the body in the dose setting operation.

3. The assembly of claim 1, wherein the drive member is configured to rotate and move in an axial direction in the dose setting operation.

4. The assembly of claim 1, wherein the piston rod is threadedly engaged with the drive member.

5. The assembly of claim 1, wherein the drive member is in splined connection with the dose setting part.

6. The assembly of claim 1, wherein the drive member, in the dose dispensing operation, is configured to axially move in a distal direction while being prevented from rotating, and wherein rotational movement of the drive member in the dose dispensing operation is prevented by an engagement part being engaged in an axial track of the body or of a component permanently locked to the body.

7. The assembly of claim 6, wherein the dose setting part comprises the engagement part.

8. The assembly of claim 6, wherein the drive member comprises the engagement part.

9. The assembly of claim 6, wherein the drive member or a component locked to the drive member comprises a prime-lock part, wherein the body or the component permanently locked to the body comprises a further prime-lock part, and wherein the prime-lock part and the further prime-lock part directly or indirectly interact with each other, thereby preventing the dose setting operation prior to a priming operation.

10. The assembly of claim 9, wherein the dose setting operation is carried out by rotating the dose setting part and the priming operation comprises pushing a dose dispense part towards the body.

11. The assembly of claim 9, wherein the prime-lock part is able to pass the further prime lock part or the engagement part in the dose setting operation.

12. The assembly of claim 11, wherein the drive member comprises a lock-out part and the body or the component permanently locked to the body comprises an additional lock-out part, wherein the lock-out part and the additional lock-out part interact after the dose has been set and dispensed for preventing a further dose setting operation after the dose has been dispensed.

13. The assembly of claim 12, wherein the additional lock-out part comprises a circumferential protrusion having an opening, wherein the lock-out part moves through the opening during the dose setting operation.

14. The assembly of claim 12, comprising a non-return member for preventing a proximal movement of the piston rod, wherein the non-return member comprises at least one of the additional lock-out part or a track for guiding the engagement part.

15. A medication delivery device comprising: an assembly having: a body, a user operated dose setting part for selecting a size of a dose in a dose setting operation, a piston rod configured to be moved axially without rotating for dispensing a medication in a dose dispensing operation, and a drive member directly coupled to the piston rod for driving the piston rod in the dose dispensing operation, wherein the drive member moves in a proximal direction in the dose setting operation, wherein the dose setting part is coupled to the drive member such that a relative movement between the dose setting part and the drive member is enabled during the dose setting operation, and wherein the medication delivery device is an injection device.

16. The medication delivery device of claim 15, wherein the injection device is a variable-dose, single-use device.

Description

BRIEF DESCRIPTION OF THE DRAWINGS

(1) FIG. 1 schematically shows a perspective view of a medication delivery device.

(2) FIG. 2 schematically shows a cross-sectional view of the medication delivery device.

(3) FIG. 3 schematically shows an exploded view of the medication delivery device.

(4) FIG. 4 schematically shows a perspective view of a main part of a body of the medication delivery device.

(5) FIG. 5 schematically shows a perspective view of a detail of the drive member and the dose setting part during prime-lock.

(6) FIG. 6 schematically shows a sectional side view of the medication delivery as supplied from the manufacturer.

(7) FIG. 7 schematically shows a sectional side view of the medication delivery in a primed state.

(8) FIG. 8 schematically shows a sectional side view of the medication delivery after a dose setting operation.

(9) FIG. 9 schematically shows a sectional side view of the medication delivery after a dose dispensing operation.

(10) FIG. 10 schematically shows a perspective view of a medication delivery device according to a second embodiment.

(11) FIG. 11 schematically shows a cross-sectional view of the medication delivery device of the second embodiment.

(12) FIG. 12 schematically shows an exploded view of the medication delivery device of the second embodiment.

(13) FIG. 13 schematically shows a perspective view of a main part of a body of the medication delivery device.

(14) FIG. 14 schematically shows a sectional side view of the medication delivery of the second embodiment as supplied from the manufacturer.

(15) FIG. 15 schematically shows a sectional side view of the medication delivery of the second embodiment in a primed state.

(16) FIG. 16 schematically shows a sectional side view of the medication delivery of the second embodiment after a dose setting operation.

(17) FIG. 17 schematically shows a sectional side view of the medication delivery of the second embodiment after a dose dispensing operation.

(18) FIG. 18 schematically shows a sectional side view of parts of a medication delivery device according to a further embodiment.

DETAILED DESCRIPTION OF THE INVENTION

(19) Like elements, elements of the same kind and identically acting elements may be provided with the same reference numerals in the figures.

(20) FIG. 1 shows a perspective view of a medication delivery device 1. The device 1 is adapted to retain a medication, in particular a liquid medication. The device 1 is a variable dose device such that the size of a dose to be administered is variable by a user.

(21) The device 1 may be a single-shot device. This means that the device 1 is intended for a single use, i.e., for administering only one dose of medication. The device 1 may be configured to be primed before a dose is administered. The priming operation serves to remove tolerances between the mechanical components and does not comprise administering a dose of medication. After a single use, the device 1 may be discarded. The device 1 may comprise a lock-out mechanism which may prevent a further dose dispensing operation once a single dose has been dispensed. In particular, the lock-out mechanism may prevent a further dose dispensing operation by preventing a further dose setting operation.

(22) The device 1 comprises a body 2. The body 2 may be designed to enable a safe and comfortable handling of the medication delivery device 1. The body 2 may be a unitary or multipart component. The body 2 may comprise a cylindrical shape. The device 1 may have a pen-type shape.

(23) The body 2 comprises a main part 3 that may house, fix, protect and guide inner components of the device 1. The body 2 comprises a retainer part 4 for retaining the medication. The retainer part 4 may be a cartridge holder for holding a cartridge containing the medication. Alternatively, the medication may be directly retained in the body 2, in particular in the retainer part 4, without that a cartridge is provided. The retainer part 4 may be connected, e.g., snap-fitted or screwed to the main part 3. Alternatively, the retainer part 4 may be unitary with the main part 3.

(24) The device 1 comprises a needle 5 at its distal end 6. The needle 5 may be part of a needle assembly 7 which may be connected, e.g., screwed to a distal end of the body 2, in particular to the distal end of the retainer part 4.

(25) The device 1 comprises a dose setting part 8 for setting a dose of the medication. The dose setting part 8 is located near to the proximal end 9 of the device 1. The dose setting part 8 is configured to be directly operated by a user for setting a dose to be dispensed.

(26) In particular, for setting a dose, the user grips the dose setting part 8 and rotates the dose setting part 8 until a desired size of the dose is selected. During such a dose setting operation, the dose setting part 8 may carry out a purely rotational movement. In an alternative embodiment, the dose setting part 8 may carry out a combined rotational and axial movement in the proximal direction.

(27) The size of the set dose is visible through a window 10 provided in the body 2, in particular in the main part 3. The window 10 may also show specific states of the device 1. As an example, the window 10 may indicate that a dose setting operation has not been carried out yet. This state may be indicated by the numeral “P”.

(28) The device 1 may comprise a further window 11 for displaying specific states of the device 1. As an example, the further window 11 may indicate a primed state or a locked-out state of the device 1. The further window 11 may be located in the dose setting part 8, for example.

(29) The device 1 further comprises a drive member 12 for driving a piston rod 13 (see FIG. 2) in a dose dispensing operation. The drive member 12 is directly coupled with the piston rod 13. In FIG. 1, the drive member 12 visibly protrudes out at of a proximal end of the body 2. This may indicate that the device 1 is ready to prime.

(30) During a dose setting operation, the drive member 12 moves in a proximal direction whereby the overall length of the device 1 increases. The drive member 12 may carry out a combined rotational and axial movement during a dose setting operation.

(31) The device 1 further comprises a dispense part 14 for dispensing a dose. The dispense part 14 is configured to be operated by a user, in particular pushed towards the body 2. The dispense part 14 is permanently locked to the drive member 12, for example by a snap-fit connection. The drive member 12 may carry out a purely axial movement in the distal direction during a dose dispensing operation. The dispense part 14 may have the shape of a cap.

(32) The device 1 is shown in an unprimed state. A priming operation may be carried out by pushing the dispense part 14 towards the body 2.

(33) In the following, the structure of the medication delivery device 1 is described in detail in connection with FIGS. 2, 3, 4 and 5, wherein FIG. 2 shows a cross-sectional view of the device 1, FIG. 3 shows an exploded view of the device 1, FIG. 4 shows a perspective view of the main part 3 of the body 2 and FIG. 5 shows a perspective view of a detail of the drive member 12 and the dose setting part 8 during prime-lock.

(34) The piston rod 13 is an elongate component which is moved in the distal direction for expelling the medication. The piston rod 13 acts on a dose 15 retained in a cartridge 16. The cartridge 16 is sealed by a septum 17 pierced by the needle 5. In an alternative embodiment, the distal end of the piston rod 13 is in direct contact with the medicament and directly presses the medicament out of the device 1.

(35) The piston rod 13 is axially movable in the distal direction with respect to the body 2 for expelling the medication. The piston rod 13 is permanently prevented from rotating relative to the body 2. A non-return member 18 is engaged with the piston rod 13 and prevents a movement of the piston rod 13 in the proximal direction. The non-return member 18 is permanently locked to the body 2. The non-return member 18 may be locked to the body 2 by a snap-fit connection, for example.

(36) The piston rod 13 comprises several teeth 19, 20, 21 for engaging a ratchet arm 22 of the non-return member 18. A further ratchet arm 22 and corresponding teeth 19, 20, 21 are also provided on an opposite side of the piston rod 13 and the non-return member 18, respectively.

(37) When the ratchet arm 22 is located at a proximal side of one of the teeth 19, 20, 21, a movement of the piston rod 13 in the proximal direction is prevented due to a steep proximal wall of each of the teeth 19, 20, 21. A movement in a distal direction is enabled by a less steep distal wall of each of the teeth 19, 20, 21. The force required for snapping over the teeth 19, 20, 21 is defined by the steepness of the distal walls.

(38) The ratchet arm 22 snaps over the first and second tooth 19, 20 during a priming operation. The ratchet arm 22 snaps over the third tooth 21 during a dose setting operation. The distal walls of the first and third teeth 19, 21 are steeper than the distal wall of the second tooth 20 such that the user has to overcome an initial high resistance to start a priming and a dispensing operation, respectively.

(39) The non-return member 18 also prevents a rotational movement of the piston rod 13. For this aim, the piston rod 13 comprises a groove 23 (see FIG. 3), extending in an axial direction. The groove 23 may extend along the full length of the piston rod 13. The non-return member 18 comprises an axial protrusion 24 (see FIG. 3) which is engaged with the groove 23 and, thereby, guides the piston rod 13 and prevents a rotational movement of the piston rod 13. Such a groove 23 and a corresponding protrusion 24 are provided at two opposite sides of the piston rod 13 and the non-return member 18, respectively.

(40) In addition to that, a rotation of the piston rod 13 may additionally be prevented by the non-circular cross section of the piston rod 13 and the abutment of the ratchet arms 22 of the non-return member 18 on the piston rod 13. Alternatively or additionally, a part different from the non-return member 18 may prevent a rotational movement of the piston rod 13.

(41) The piston rod 13 comprises a thread 25 (see FIG. 3) engaging a corresponding thread 26 (see FIG. 3) of the drive member 12. The threads 25, 26 may be configured as multi-start threads to increase the engagement strength of the threads 25, 26.

(42) The drive member 12 has the shape of a sleeve and partially encloses the piston rod 13. The thread 26 of the drive member 12 is located at a distal part 27 (see FIG. 3) of the drive member 12. The distal part 27 has a smaller diameter than a proximal part 28 (see FIG. 3) of the drive member 12. The differing diameters are provided for allowing the drive member 12 to be engaged both with the piston rod 13 and with the dose setting part 8.

(43) The drive member 12 is in splined engagement with the dose setting part 8. In particular, the drive member 12 comprises an elongate rib 29 (see FIG. 3) located at the proximal part 28 which engages an elongate groove (not depicted) in the interior of the dose setting part 8. A further elongate rib and a further elongate groove is located at an opposite side of the drive member 12 and the dose setting part 8, respectively. The splined engagement permanently prevents a rotational movement of the dose setting part 8 relative to the drive member 12.

(44) The dose setting part 8 is axially fixed to the body 2 but rotatable relative to the body 2 for allowing a dose setting operation. In particular, the dose setting part 8 comprises one or more recesses 30 (see FIG. 3), which are engaged with a circumferential protrusion 31 (see FIG. 4) in the interior of the main part 3 of the body 2. The circumferential protrusion 31 has an opening 42 (see FIG. 4) which enables parts of the drive member 12 to pass the protrusion 31 and thereby, enable the drive member 12 to move proximally in a dose setting operation.

(45) The dose setting part 8 comprises an engagement part 32 which is located at a deflectable part 43 of the dose setting part 8 (see FIG. 5). The deflectable part 43 may have the shape of a bridge being connected at both ends to a main part of the dose setting part 8. The deflectable part 43 may be defined by an opening 44 in the dose setting part 8. The deflectable part 43 is enabled to deflect radially inwards.

(46) The engagement part 32 is configured to be engaged with a track 33 (see FIG. 4) in the main part 3 of the body 2 before priming, during priming and during a dose dispensing operation. The main part 3 of the body 2 comprises a plurality of such tracks 33 for allowing the setting and dispensing of doses in discrete steps. Each of the tracks 33 is an axially extending groove in an interior part of the body 2. In the unprimed state the engagement part 32 is engaged with a priming track 39.

(47) The drive member 12 comprises a prime-lock part 34 which is located beneath the engagement part 32 in the unprimed state of the device 1. The prime-lock part 34 disables the deflectable part 43 and, thereby, the engagement part 32 from deflecting radially inwards and, thereby, disables the engagement part 32 from disengaging the track 33, in particular the priming track 39. Thereby, in the unprimed state, a rotation of the dose setting part 8 is prevented. Accordingly, the prime-lock part 34 blocks the device 1 from being used in a dose setting operation and a dose dispensing operation until a priming operation has been carried out.

(48) The dose setting part 8 carries markings 35 on its outer surface visible through the window 10 in the main part 3. The markings 35 indicate the size of a set dose. The markings 35 may comprise dose numbers. Furthermore, the marking 35 may comprise one or more symbols indicating a specific state of the device 1.

(49) The drive member 12 comprises a lock-out part 36 for locking the device 1 after a dose dispensing operation. The lock-out part 36 comprises a deflectable protrusion. The protrusion may have the shape of a cantilever. At the end of a dispensing operation, the lock-out part 36 may snap over the circumferential protrusion 31. The circumferential protrusion 31 has a steep distal side face such that a backwards movement of the lock-out part 36 is prevented. The circumferential protrusion 31 has a less steep proximal side face such that the lock-out part 36 is enabled to snap over the circumferential protrusion 31 when being moved in a distal direction. The circumferential protrusion 31 is a further lock-out part 37, interacting with the lock-out part 36.

(50) The drive member 12 carries one or more markings 38 on its outer surface for indicating specific states of the device 1. In particular, the markings 38 comprise one or more colored rings. The markings 38 may indicate a pre-primed state or a locked state of the device 1, for example. The markings 38 are visible through the further window 11 at certain states of the device 1.

(51) The assembled mechanical components such as the drive member 12, the piston rod 13 and further components may be denoted as an assembly 47 of the device 1.

(52) In the following, the operation of the medication delivery device 1 is described in detail in connection with FIGS. 6, 7, 8 and 9. The figures show the body 2 in a cross-sectional view and the further components of the medication delivery device 1 in a perspective view.

(53) FIG. 6 shows the device 1 as supplied from the manufacturer. The device 1 is in an unprimed state.

(54) The unprimed state may be indicated by a specific color visible in the further window 11. In particular, one of the markings 38 embodied as colored rings located on the drive member 12 is visible. The priming operation serves to remove the tolerances between mechanical components. In the priming operation, a small amount of medication may be pressed out of the device 1 without being administered to a user.

(55) In the unprimed state, a dose setting operation is prevented by the prime-lock part 34 (see FIG. 5) of the drive member 12 holding the engagement part 32 of the dose setting part 8 in engagement with the track 33 in the body 2. The track 33 functions as a further prime-lock part 41, interacting indirectly with the prime-lock part 34 via the engagement part 32. In particular, the further prime-lock part 41 may correspond to a priming track 39 adjacent to a radially outwards recessed area 45 of the body 2. By the indirect interaction of the prime-lock parts 34, 41, a rotation of the dose setting part 8 relative to the body 2 is prevented. In this state, the drive member 12 protrudes out of the dose setting part 8.

(56) For priming the device 1, the user pushes the dispense part 14 towards the body 2. Thereby, the drive member 12 is driven in the distal direction. A rotation of the drive member 12 is prevented by the splined engagement with the dose setting part 8 and by the engagement of the engagement part 32 of the dose setting member 8 in the axial track 33 in the body 2.

(57) Due to the threaded engagement of the piston rod 13 with the drive member 12, the piston rod 13 is driven in the distal direction by the distal movement of the drive member 12. The dose 15 is moved forward by the piston rod 13 and a priming dose is dispensed from the device 1.

(58) During the advancement of the piston rod 13, each ratchet arm 22 moves over the first priming tooth 19 and over the second priming tooth 20. The snapping of the ratchet arms 22 over the second priming teeth 20 indicates the end of the priming operation by an audible and tactile feedback.

(59) FIG. 7 shows the device 1 in its primed state, i.e., after a priming operation has been performed.

(60) The dispense part 14 is fully depressed. The primed state of the device 1 is indicated by a different color appearing in the further window 11.

(61) Each ratchet arm 22 is located between the second priming tooth 20 and the third tooth 21.

(62) The prime-lock part 34 of the drive member 12 is located at a distal offset from the engagement part 32. The engagement part 32 is now free to deflect radially inwards and disengage from the track 33 when a rotational force is applied to the dose setting part 8.

(63) In this state, a rotation of the dose setting part 8 and, thereby, a setting of a dose is enabled.

(64) FIG. 8 shows the device 1 after a dose setting operation.

(65) For setting a dose, the user grips and rotates the dose setting part 8, e.g., in an anti-clockwise direction when viewing from the proximal end towards the distal end. A rotation of the dose setting part 8 in the opposite direction may be prevented due to the specific shape of the sidewalls of the tracks 33 in the main part 3 of the body 2. In an alternative design, a rotation in the opposite direction may be allowed, e.g., to reduce the set dose.

(66) During the rotation of the dose setting part 8, the engagement part 32 moves over the tracks 33 until a desired dose is set and displayed in the window 10. Each time the engagement part 32 engages with one of the tracks 33 an audible and/or tactile feedback may be produced. Accordingly, during dose setting, the increase of the size of the dose is indicated in a step-like manner. When the desired dose has been set, the engagement part 32 is engaged in one of the tracks 33 and the device is ready for a dispensing operation.

(67) During the dose setting operation, the dose setting part 8, carries out a purely rotational movement due to the coupling with the body 2. Due to the splined engagement of the dose setting part 8 with the drive member 12, the drive member 12 is rotated. In addition to that, due to the threaded coupling of the drive member 12 with the piston rod 13, the drive member 12 also moves in a proximal direction. A proximal movement of the piston rod 13 is prevented by the ratchet arms 22 of the non-return member 18.

(68) The circumferential protrusion 31 has an opening 42, which enables the lock-out part 36 of the drive member 12 to pass the circumferential protrusion 31. Furthermore, at the start of a dose setting operation, the engagement part 32 first moves along an area 45 recessed radially outwards, which enables the lock-out part 36 to pass the engagement part 32.

(69) During the dose setting operation, the overall length of the device 1 increases. Now, the device 1 is ready for delivering the set dose of the medication.

(70) FIG. 9 shows the device 1 after the dose has been dispensed.

(71) For delivering the set dose, the user fully depresses the dispense part 14. Thereby, the drive member 12 is moved in a distal direction. A rotation of the drive member 12 is prevented by the splined engagement of the drive member 12 with the dose setting part 8 and by the engagement of the engagement part 32 of the dose setting part 8 in a track 33 in the body 2. Accordingly, the dose setting part 8 does not move during a dose dispensing operation. The dose displayed in the window 10 does not change during the dose dispensing operation.

(72) Due to the threaded engagement of the drive member 12 with the piston rod 13, the piston rod 13 is driven in the distal direction. The third tooth 21 passes the ratchet arm 22 and the ratchet arm 22 slides along a flat surface of the piston rod 13. The piston rod 13 pushes the dose 15 further in distal direction, thereby expelling medication through the needle 5.

(73) Due to the rotation of the drive member 12 in the dose setting operation, the drive member 12 is in a different rotational orientation than at the beginning of the dose setting operation. In particular, the lock-out part 36 is located at an angular offset from the opening 42 and is not aligned with the opening 42. In this orientation, the lock-out part 36 interacts with the circumferential protrusion 31 at the end of the distal movement of the drive member 12. In particular, the lock-out part 36 deflects and snaps over the circumferential protrusion 31. A backwards movement of the lock-out part 36 is prevented by a steep distal face of the circumferential protrusion 31. Thereby, a proximal movement of the drive member 12 is disabled and a setting of a further dose of medication is prevented. Accordingly, the circumferential protrusion 31 is a further lock-out part.

(74) The device 1 is now locked. No further dose of the medication can be set and dispensed from the device 1. The locked state is indicated by a specific color appearing in the further window 11.

(75) FIGS. 10 to 17 relate to a second embodiment of a medication delivery device 1. In the following, primarily the main differences to the first embodiment shown in the foregoing figures are described in detail. The further structural and functional elements may correspond to the first embodiment.

(76) FIG. 10 shows a perspective view of the second embodiment of a medication delivery device 1.

(77) The device 1 comprises a dose setting part 8 for setting and, thereby selecting a size of a dose. The dose setting part 8 is unitary or permanently locked with the dispense part 14. The dose setting part 8 and the dispense part 14 are permanently locked with the drive member 12 (see FIG. 11). Accordingly, the dose setting part 8 is not located at a component which carries out relative movements to the drive member 12.

(78) The dose setting part 8 may be permanently locked to the drive member 12. The dose setting part 8 is snap-fitted to the drive member 12, for example. The dose setting part 8 is designed as a cap having a gripping surface at its side face.

(79) In the second embodiment, the functions which the dose setting part 8 fulfills in the first embodiment are fulfilled in parts by the drive member 12 and in parts by the dose setting part 8 locked to the drive member 12. Accordingly, the second embodiment comprises one separately movable component less than the first embodiment.

(80) The device 1 comprises only a single window 10. The window 10 displays the size of a selected dose and may additionally display specific states of the device 1.

(81) In the following, the structure of the medication delivery device 1 of the second embodiment is described in detail in connection with FIGS. 11, 12 and 13, wherein FIG. 11 shows a cross-sectional view of the medication delivery device 1, FIG. 12 shows an exploded view of the medication delivery device 1 and FIG. 13 schematically shows a perspective view of a main part 3 of the body 2 of the device 1.

(82) The drive member 12 comprises an engagement part 32 corresponding to the engagement part 32 located on the dose setting part 8 of the first embodiment. The engagement part is not visible in FIG. 12, because it is located at an averted side of the drive member 12. The position of the engagement part 32 is indicated in FIG. 12.

(83) The engagement part 32 is located at an inwardly deflectable part of the drive member 12. The deflectable part may have a bridge-like shape as described for the first embodiment. The engagement part 32 is configured to releasably engage axial tracks 33 (see FIG. 13) in the interior of the body 2.

(84) The drive member 12 comprises several sets of markings 35, 38 and one prime-lock marking 46. The first set of markings 35 extends helically around the drive member 12. The second set of markings 38 extends circularly around the drive member 12. The different sets of markings 35, 38 are required in order to display the set dose both during setting and after a dispensing operation. Due to the axial movement of the drive member 12 in a dispensing operation, the first set of markings 35 is not visible through the window 10 after the dose is dispensed.

(85) The dose setting part 8 comprises a prime-lock part 40 located at an inner surface. The prime-lock part 40 is a short rib extending in an axial direction. The prime-lock part 40 interacts with two further prime-lock parts 41 (see FIG. 13) located at an outer surface of the body 2. The further prime-lock parts 41 are located at the proximal end of the main part 3. The further prime-lock parts 41 are short ribs extending in the axial direction, arranged parallel to each other.

(86) In an unprimed state of the device 1, the prime-lock part 40 is located between the further prime-lock parts 41. Thereby, any rotation of the dose setting part 8 is prevented.

(87) In the following, the operation of the medication delivery device 1 is described in detail in connection with FIGS. 14, 15, 16 and 17. The figures show the body 2 in a cross-sectional view and the further components of the medication delivery device 1 in a perspective view.

(88) FIG. 14 shows the device 1 as supplied from the manufacturer. The device 1 is in an unprimed state.

(89) The unprimed state may be indicated by the prime-lock marking 46 (see FIG. 12) visible in the window 10. The prime-lock marking 46 may comprise a specific symbol, such as a symbol of a lock, or a color. Thereby, a user is informed that a priming operation is required before the device 1 is usable in a dose setting and dose dispensing operation.

(90) In the unprimed state, a dose setting operation is prevented by the prime-lock part 40 of the dose setting part 8 being positioned between the prime-lock parts 41 at the body 2.

(91) For priming the device 1, the user pushes the dispense part 14 and, thereby the drive member 12, towards the body 2. A rotation of the drive member 12 is prevented by the engagement of the engagement part 32 in one of the axial tracks 33 in the body 2.

(92) Due to the threaded engagement of the piston rod 13 with the drive member 12, the piston rod 13 is driven in the distal direction and a small amount of medication is dispensed. The interaction of the non-return member 18 and the piston rod 13 is the same as described for the first embodiment.

(93) FIG. 15 shows the device 1 in its primed state, i.e., after a priming operation has been performed.

(94) The dispense part 14 is fully depressed. The primed state of the device 1 is indicated by a different color or symbol appearing in the window 10. In particular, one of the markings of the second set of markings 38 appears in the window 10. As an example a “P” may be displayed for indicating the primed state.

(95) During the priming operation, the prime-lock part 40 on the dose setting part 8 moves out of engagement with the further prime-lock parts 41 of the body 2. The prime-lock part 40 are now located at an axial offset from the further prime-lock parts 41.

(96) In this state, a rotation of the dose setting part 8 and, thereby, a setting of a dose is enabled.

(97) FIG. 16 shows the device 1 after a dose setting operation.

(98) For setting a dose, the user grips and rotates the dose setting part 8. Due to the threaded engagement of the drive member 12 with the piston rod 13, the drive member 12, together with the dose setting part 8, moves in a proximal direction.

(99) Due to the rotational movement of the dose setting part 8, the prime-lock part 40 is angularly misaligned from the further prime-lock parts 41 and, thereby, is enabled to ass the further prime-lock parts 41 when the dose setting part 8 moves in the proximal direction.

(100) During the rotation of the dose setting part 8, the engagement part 32 moves over the tracks 33 until a desired dose is set and displayed by one of the markings of the first set of markings 35 appearing in the window 10. When the desired dose has been set, the engagement part 32 is engaged in one of the tracks 33 and the device 1 is ready for a dispensing operation.

(101) During the dose setting operation, the overall length of the device 1 increases. Now, the device 1 is ready for delivering the set dose of the medication.

(102) FIG. 17 shows the device 1 after the dose has been dispensed. For delivering the set dose, the user fully depresses the dispense part 14.

(103) Thereby, the drive member 12 drives the piston rod 13 in a distal direction. A rotation of the drive member 12 is prevented by engagement of the engagement part 32 in a track 33 in the body 2.

(104) The lock-out part 36 interacts with the circumferential protrusion 31 at the end of the dose dispensing operation, as described for the first embodiment, and locks the device 1. The locked state and/or the size of the dispensed dose is indicated by a specific marking of the second set of markings 38 appearing in the window 10.

(105) FIG. 18 schematically shows a sectional side view of parts of a medication delivery device 1 according to an embodiment where the device 1 is a pre-filled syringe.

(106) In this embodiment, the medication is directly retained in the body 2 without that a separate cartridge is provided. The body 2 may have a single-part design. Alternatively, the body 2 may have a multiple-part design. The further structural and functional elements may be configured as described for the embodiments of the foregoing figures.